Quantitative detection of bacterial endotoxin by novel nanotechnological approac...
Quantitative detection of bacterial endotoxin by novel nanotechnological approaches
ENDONANO (Quantitative detection of bacterial endotoxin by novel nanotechnological approaches) addresses a key regulatory and safety issue, i.e., the unbiased quantitative detection of bacterial endotoxin in products for medical u...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
NANOTESTS
Fabrication and development of nanotoxicology test bacterial...
224K€
Cerrado
PCI2019-103715
NANOPARTICULAS MAGNETICAS AVANZAS PARA DETECCION Y CUANTIFIC...
59K€
Cerrado
PCI2019-103600
NANOPARTICULAS MAGNETICAS AVANZAS PARA DETECCION Y CUANTIFIC...
145K€
Cerrado
NANOTOX
Nanoparticle Cell Interactions a Pathway for Understandin...
100K€
Cerrado
REBELLION
Light REsponsive Nanomachines for Targeted Eradication of Ba...
246K€
Cerrado
PID2020-114347RB-C31
DISEÑO Y SINTESIS DE NANOPARTICULAS MOLECULARES Y BIOMOLECUL...
133K€
Cerrado
Información proyecto ENDONANO
Duración del proyecto: 59 meses
Fecha Inicio: 2018-07-19
Fecha Fin: 2023-06-30
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
ENDONANO (Quantitative detection of bacterial endotoxin by novel nanotechnological approaches) addresses a key regulatory and safety issue, i.e., the unbiased quantitative detection of bacterial endotoxin in products for medical use and in drug development and toxicological studies. The currently adopted LAL assays are reliable only in limited conditions and prone to interference at several levels, and therefore cannot be applied to all products and substances. ENDONANO will exploit new concepts, based on the capacity of metal nanoparticles to adsorb endotoxin, and new detection methods, based on molecular beacons, for developing novel assays to quantitatively detect endotoxin in complex matrices and in a wide range of conditions. The scientific and technological goals of ENDONANO include: 1. Investigating the capacity of endotoxin to specifically inducing inflammatory reactions in human primary blood cells; 2. Developing new methods based on endotoxin capture by metal nanoparticles in complex matrices (biological fluids, emulsions, gels, etc.); 3. Designing and implementing signal generation and detection methods for the quantitative endotoxin measurement; 4. Planning assay prototypes to be developed and validated for commercial purposes. ENDONANO will train 4 PhD students in an overarching training programme that will include training-by-research, courses of technical, scientific, and transferrable skills, active participation to public scientific events, and intense intersectoral networking. The ENDONANO consortium encompasses three academic institutions with strong expertise in inflammation, advanced biosensing, and top expertise in nanotechnology and use of nanoparticles for modulating bacterial functions, two SMEs expert in development and commercialisation of diagnostic detection assays and one biotech company specialised in (magnetic) microbead technology, and two Participant Organisations (SMEs). All have proven experience in higher education and training,